Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multicentre, Randomized, Double-blind, Placebo-controlled, Interventional Study on Efficacy and Safety of Standardized Fraction of Picrorhiza Kurroa Royal Ex Benth (Picroliv®) for 24 Weeks in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)

NCT07452744 is registered in ClinicalTrials.gov with Bioagile Therapeutics Pvt. Ltd. as lead sponsor.

NCT NCT07452744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07452744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multicentre, Randomized, Double-blind, Placebo-controlled, Interventional Study on Efficacy and Safety of Standardized Fraction of Picrorhiza Kurroa Royal Ex Benth (Picroliv®) for 24 Weeks in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)
Lead sponsor
Bioagile Therapeutics Pvt. Ltd.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
August 13, 2024
Completion date
August 15, 2026
Enrollment
170 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

non alcholic fatty liver disease